Article
Evaluation of the genetic toxicity of sofosbuvir and simeprevir with and without ribavirin in a human-derived liver cell line.
Anais da Academia Brasileira de Ciencias - 1 Jan 2021
Librelotto Carina S, Souza Ana Paula DE, Álvares-DA-Silva Mário R, Simon Daniel, Dihl Rafael R
Abstract excerpt
Direct-acting antivirals have revolutionized the treatment of chronic hepatitis C. Sofosbuvir and simeprevir are prescribed worldwide. However, there is a scarcity of information regarding their genotoxicity. Therefore, the present study assessed the cytotoxic and genotoxic effects of sofosbuvir and simeprevir, alone and combined with ribavirin. HepG2 cells were analyzed using the in vitro cytokinesis-block...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
